Intervention Review

Natalizumab for induction of remission in Crohn's disease

  1. John K MacDonald*,
  2. John WD McDonald

Editorial Group: Cochrane IBD Group

Published Online: 24 JAN 2007

Assessed as up-to-date: 26 SEP 2006

DOI: 10.1002/14651858.CD006097.pub2


How to Cite

MacDonald JK, McDonald JWD. Natalizumab for induction of remission in Crohn's disease. Cochrane Database of Systematic Reviews 2007, Issue 1. Art. No.: CD006097. DOI: 10.1002/14651858.CD006097.pub2.

Author Information

  1. Robarts Research Institute, Robarts Clinical Trials, London, Ontario, Canada

*John K MacDonald, Robarts Clinical Trials, Robarts Research Institute, P.O. Box 5015, 100 Perth Drive, London, Ontario, N6A 5K8, Canada. jmacdon1@uwo.ca . jmacdonald@robarts.ca.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 24 JAN 2007

SEARCH